Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Treatment of human cells derived from myoclonic epilepsy and ragged red fibre (MERRF) disease by peptide-mediated mitochondrial delivery

Tuesday, 20 August 2013, 10am to 11am

NDOG Lecture Theatre, L3, Women’s Centre

Dr Chin San Lui, director of the Vascular and Genomic Centre in Taiwan